Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pulmonary pharmacology and therapeutics

  • Pulmonary pharmacology and therapeutics
  • Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
    Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros
    ERJ Open Research Oct 2020, 6 (4) 00152-2020; DOI: 10.1183/23120541.00152-2020
  • Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
    Silke van Koningsbruggen-Rietschel, Jane C. Davies, Tacjana Pressler, Rainald Fischer, Gordon MacGregor, Scott H. Donaldson, Knut Smerud, Nils Meland, Jann Mortensen, Marie Ø. Fosbøl, Damian G. Downey, Astrid H. Myrset, Hugo Flaten, Philip D. Rye
    ERJ Open Research Oct 2020, 6 (4) 00132-2020; DOI: 10.1183/23120541.00132-2020
  • The six million dollar man
    Mathilde Volpato, Stefan Nowak, Jean Luc Bourrain, Pascal Demoly, Engi Ahmed, Arnaud Bourdin, Jeremy Charriot
    ERJ Open Research Jan 2020, 00341-2020; DOI: 10.1183/23120541.00341-2020
  • The use of β2-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines
    Gustavo Nino, Carlos E. Rodríguez-Martínez, Jose A. Castro-Rodriguez
    ERJ Open Research Oct 2020, 6 (4) 00135-2020; DOI: 10.1183/23120541.00135-2020
  • Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
    Sarah Orfanos, Ibrahim El Husseini, Thomas Nahass, Jared Radbel, Sabiha Hussain
    ERJ Open Research Oct 2020, 6 (4) 00455-2020; DOI: 10.1183/23120541.00455-2020
  • Response to mepolizumab treatment is sustained across 4-weekly dosing periods
    Ian D. Pavord, Eugene R. Bleecker, Roland Buhl, Pascal Chanez, Elisabeth H. Bel, Peter Howarth, Daniel J. Bratton, Frank C. Albers, Steven Yancey
    ERJ Open Research Jul 2020, 6 (3) 00068-2020; DOI: 10.1183/23120541.00068-2020
  • Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
    Tim Harrison, Ian D. Pavord, James D. Chalmers, Glenn Whelan, Malin Fagerås, Annika Rutgersson, Laura Belton, Shahid Siddiqui, Per Gustafson
    ERJ Open Research Apr 2020, 6 (2) 00333-2019; DOI: 10.1183/23120541.00333-2019
  • Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
    Patricia van Velzen, Gerben ter Riet, Paul Brinkman, Peter J. Sterk, Jan M. Prins
    ERJ Open Research Apr 2020, 6 (2) 00099-2020; DOI: 10.1183/23120541.00099-2020
  • Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
    Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky
    ERJ Open Research Apr 2020, 6 (2) 00187-2019; DOI: 10.1183/23120541.00187-2019
  • Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis
    Katherine B. Hisert, Timothy P. Birkland, Kelly Q. Schoenfelt, Matthew E. Long, Brenda Grogan, Suzanne Carter, W. Conrad Liles, Edward F. McKone, Lev Becker, Anne M. Manicone
    ERJ Open Research Apr 2020, 6 (2) 00318-2019; DOI: 10.1183/23120541.00318-2019

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Acute lung injury and critical care (21)
  • Asthma and allergy (108)
  • CF and non-CF bronchiectasis (71)
  • COPD and smoking (186)
  • Epidemiology, occupational and environmental lung disease (42)
  • Genetics (12)
  • Interstitial and orphan lung disease (93)
  • Lung biology and experimental studies (43)
  • Lung cancer (51)
  • Lung imaging (24)
  • Lung structure and function (47)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (53)
  • Pulmonary pharmacology and therapeutics (58)
  • Pulmonary vascular disease (36)
  • Respiratory clinical practice (69)
  • Respiratory infections and tuberculosis (161)
  • Sleep medicine (37)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series
  • COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society